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ABSTRACT 
Objectives: To evaluate the perinatal outcomes of antenatally diagnosed omphalocele cases. 
Material and methods: This was a retrospective study conducted between July 2014 and 
February 2020 at the prenatal diagnosis center of a university clinic. Gestational week of 
diagnosis, associated anomalies, karyotype analysis results, complications during pregnancy, 
termination/delivery characteristics, and postnatal results were evaluated.  
Results: The analysis was performed on 58 patients. The median diagnosis time was 14.5 
weeks of gestation. Thirty-three cases (57%) were defined in the first trimester. 33 (57%) of 
58 patients had one or more concomitant anomalies, while 25 patients (43%) had isolated 
omphalocele. The most common associated anomaly was a cardiac anomaly which was 
observed in 17 fetuses (30% of all omphalocele cases). Karyotype analysis was performed in 
forty-five patients (41 in the prenatal period, 4 in the postnatal period). A normal karyotype 
was detected in 27 cases (60%). Trisomy 18 was the most common chromosomal anomaly (n 
= 15, 33.3%). Thirty of 58 patients (52%) requested termination of pregnancy (TOP) in the 
early pregnancy period. Thirteen of the cases died in-utero (22%). Fifteen pregnancies 
resulted in live births (26%), of those eight were lost in the first year of life (six of them had 
additional anomalies, while two of them had isolated omphalocele but the omphalocele pouch 
was containing the liver in those two babies). 
Conclusions: Most of the cases with an omphalocele can be diagnosed in the first trimester. 
Cardiac anomalies were the most common associated anomalies, while trisomy 18 is the most 
common chromosomal anomaly. Thus, earlier and effective counseling can be made about the 
prognosis of pregnancy.  
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Introduction 
Omphalocele (exomphalos) is one of the most common anterior abdominal wall defect 
and its frequency is reported to be 1 in 4000–7000 live births [1]. It is defined as herniation of 
intra-abdominal organs covered with peritoneal membrane and umbilical cord due to midline 
defect of the anterior abdominal wall. The peritoneal membrane consists of the wharton gel 
between the inner layer of the peritoneum and the outer layer of the amnion [2]. Abdominal 
wall herniation is considered physiological before the 12th gestational week. For this reason, 
the diagnosis of omphalocele is made more during the first trimester screening [3, 4] 
especially during the nuchal translucency (NT) measurement as part of first trimester 
screening [5]. This is the main reason for the high misdiagnosis rates in the first trimester. 
Detailed ultrasonographic examination including fetal echocardiography and karyotype 
analysis should be requested in terms of searching for the concomitant anomalies that have an 
increased rate in omphalocele cases. The frequency of chromosomal anomalies, especially 
trisomy 18, was higher in omphalocele cases. Trisomy 18 is present in 80% of cases if other 
anomalies accompanied to omphalocele, whereas the rate is 54% in the omphalocele cases 
accompanied with only increased NT [6]. Since omphalocele may be associated by many 
structural anomalies (Pentalogy of Cantrell, Beckwith-Wiedeman syndrom, bladder 
exstrophy, imperforate anus, spina bifida complex/OEIS complex, neural tube defects, 
diaphragmatic herniation, single gene disorders and many other syndromes) targeting detailed 
ultrasonography in the second trimester and if necessary cyto-genetic analysis such as 
comparative genetic hybridization should be performed even if it is thought to be isolated in 
the first trimester [7]. Cardiac anomalies especially secundum atrial septal defect (ASD) and 
muscular ventricular septal defect (VSD) are the most common concomitant structural 
anomalies in omphalocele cases. The most common extracardiac anomalies are in the 
genitourinary system (Pyelectasis, Hydronephrosis, Cloacal exstrophy, Multicystic kidney) 
and gastrointestinal system (Beckwith-Wiedeman syndrome). Pulmonary hypoplasia is also 
common, especially if the defect is large [8, 9]. Therefore, detailed cardiac evaluation is 
essential in these cases. 
The prognosis of the omphalocele is usually severe in non-isolated cases. 
Omphalocele sac can include liver, stomach and intestinal. There is a high termination rate 
and in-utero mortality rate for omphalocele because of the associated structural and 
chromosomal anomalies. Chromosomal anomaly and/or related structural anomaly incidence 
rate can be high as 88% for omphalocele. Therefore, live birth rate is reported to be 25–40% 
[1, 10]. But prognosis is better in isolated omphalocele cases. The most difficult question is to 
reveal whether the case is really isolated omphalocele.  
In this study, we aimed to evaluate the prenatal results of patients with omphalocele 
diagnosed and followed up in our clinic.  
 
MATERIAL AND METHODS 
This retrospective study was conducted between July 2014 and February 2020 at the 
Maternal-Fetal Unit of a University Hospital. This study was approved by the Faculty of 
Medicine Ethics Committee. This center is the tertiary referral center for the perinatal 
diagnosis. Women admitted for routine ultrasound examination or referred to our hospital for 
a suspected fetal anomaly underwent detailed fetal anomaly ultrasonography scan. For those 
detected with omphalocele and continued pregnancy, a detailed ultrasonographic evaluation 
including fetal cardiography was performed to determine associated anomalies by using 
VolusonE6 (GE Medical Systems, Zipf, Austria) with a transabdominal 4–8-MHz probe. The 
data were scanned retrospectively from the viewpoint recording system and the neonatal 
registry system. Maternal age, gravidity, parity, gestational age at diagnosis, associated 
structural malformations, whether invasive diagnostic procedures were performed or not, the 
results of karyotype analysis and fetal echocardiography results were determined. Each 
patient was evaluated in a council of clinical geneticists, pediatric surgeons and 
perinatologists. Each family was informed in detail about the current situation by the council. 
TOP were performed if the family requested the termination and the fetus was evaluated 
postmortem if the family approved this examination. The ratio of TOP was determined. 
During the follow-up, whether intrauterine growth restriction (IUGR), intrauterine fetal death, 
preterm labor were evaluated. IUGR was defined as fetal ultrasonographic measurements 
being below 10% percentile according to gestational age. Small gestational age (SGA), IUGR 
distinction was not made. Doppler studies were evaluated after the diagnosis of IUGR. 
Delivery before completing the 37th gestational weeks were defined as preterm delivery. 
Gestational age at delivery, route of delivery, low APGAR score (10th minute ≤ 5), birth 
weight, size and content of defect and postnatal information were recorded by using the labor 
unit registry and neonatal intensive care (NICU) registry. Neonatal care was performed by the 
neonatologist and the pediatric surgery team in same hospital.  
Statistically analysis was performed by using SPSS® (SPSS Inc., Chicago, IL, USA, 
version 20). Descriptive analysis was performed for this study. Continuous data was presented 
as mean±SD, median (min-max.). Categorical data was presented as n (%).  
 
RESULTS 
Seventy-four patients with omphalocele were detected during the study period. Sixteen 
of them were excluded from the study because follow-up data were not available. Analyzes 
were performed on 58 cases. Mean maternal age was 29.0 ± 6.7, primigravidity was present in 
18 (31%) cases. The median of diagnosis time was 14.5 weeks of gestation. Thirty-three cases 
(57%) were defined in the first trimester. Twenty-five cases did not have any associated 
anomalies (43%), 33 of total cases (57%) had one or more associated anomalies. Thirty of 58 
cases (52%) performed termination of pregnancy (TOP) in the early pregnancy period. 
Thirteen of the cases (22%) died in-utero. Fifteen pregnancies (26%) resulted in live births. 
Clinical and demographic variables and results were presented in Table 1.  
The most common associated anomaly is cardiac anomaly and it was observed in 17 
fetuses. Among the cardiac anomalies, atrioventricular septal defect (AVSD) was the most 
common anomaly. Central nervous system (CNS) anomalies were observed in 15 cases. 
Urogenital system anomalies were the third most common anomalies with eight cases. Other 
system anomalies most frequently belong to the skeletal system (short femur length and short 
humerus length) and were seen in six cases. Thirteen cases had multiple anomalies associated 
omphalocele. Associated anomalies and their properties are shown in Table 2. 
Karyotype analysis was performed in 41 cases in the pre-natal period and in four cases 
in the post-natal period (78%). Normal karyotype was detected in 27 cases (60%). Trisomy 18 
was the most common karyotype anomaly with 15 cases (83%). Trisomy 13 was seen in two 
cases and Turner (45, X0) was determined in one case. Results of the karyotype analysis were 
presented as Table 3. 
Preterm delivery was determined in seven cases (46%). IUGR was determined in 
seven cases (25%). Fifteen live births were performed. Mean gestational week at the delivery 
was 34.3 week. One-third of the cases have been delivered by the vaginal route. Omphalocele 
alone was not considered a cesarean indication, and the decision for cesarean was determined 
according to general obstetric indications. 10th minute low APGAR score (≤ 5) was present in 
the 3 cases. Eight of them were lost in the first year (six of them had additional anomalies, 
two cases were isolated omphalocele, but liver was also present in the pouch). There were no 
additional major organ anomalies or karyotype abnormalities of seven babies who were born 
alive and continued their lives, and the youngest was seven months old and the eldest was 
three years old. Obstetrics and neonatal outcomes of the cases were presented in the Table 4. 
 
DISCUSSION 
In our series of 58 cases, we evaluated obstetric and neonatal outcomes in cases with 
omphalocele. Due to the liberal use of ultrasonography in the antenatal period and increased 
evaluation experience and knowledge, omphalocele diagnostic accuracy is close to 100% [1]. 
In the intrauterine period, the differential diagnosis of omphalocele and gastroschisis can be 
made almost 100%. Gastroschisis was not ever misdiagnosed as omphalocele in our series. 
The sensitivity for omphalocele diagnosis in the first trimester is reported to be 90% [10, 11]. 
In our study, 33 of the 58 cases (57%) were diagnosed omphalocele correctly in the first 
trimester. The diagnosis of omphalocele in the first trimester is very important in terms of 
detecting structural and chromosomal anomalies and enabling earlier decisions about the 
pregnancy. In omphalocele cases, live birth rates are as low as 25–40% because elective TOP 
rates and in-utero exitus rates are high [10]. In our series, the TOP rate was high as 52% (n = 
30) and live birth rate was 25% (n = 15). According to a study conducted in 11 countries in 
Europe, the live birth rate for omphalocele (n = 137) was given as 41%, fetal death rate was 
22% and TOP rate was 37% [12]. 
The prognosis of omphalocele depends on concomitant structural and/or chromosomal 
anomalies [1, 2, 6–10]. Structural anomalies were associated in 57% of our cases while 
chromosomal anomalies were found in 40%. In another series of 90 cases, 69% of central 
omphalocele cases had chromosomal anomaly, while in epigastric omphalocele, this rate was 
12% [13]. They concluded that the types of the omphalocele may be different entities but as a 
result, 22% of cases live and omphalocele has poor prognosis irrespective of the types. Thus 
in a study evaluating 79 isolated omphalocele cases diagnosed in the first trimester and 
without structural and chromosomal anomalies, live birth rate was 68% and the mortality rate 
was 33% [10]. In another series of 67 cases, the rate of chromosomal anomaly was reported as 
39% like our results [14]. In another study evaluating 98 cases diagnosed in the first trimester, 
it was found that 45.9% of the cases were associated by major structural anomalies and 53.8% 
had chromosomal anomalies [6]. Fleurke-Rozema H et al. [15], reported that 141 cases with 
omphalocele 83% had additional anomalies of which 57% had a chromosomal anomaly. 
Similarly, in the presence of increased NT (> 3.5mm), chromosomal anomaly was detected in 
40.8% of cases with omphalocele [16]. A normal NT is therefore a reassuring sign, but the 
residual risk of aneuploidy may still be as high as 28% [17]. In another series, the rate of 
related structural anomaly was reported as 78.7% (26/33), and the rate of chromosomal 
anomaly was 27.6% (8/29) [18]. The most common accompanying chromosomal anomaly is 
trisomy 18 [1, 2, 8]. Trisomy 18 was the most common karyotype anomaly (15/18) in our 
series. The most common associated structural anomaly in our series was cardiac anomalies 
(17/58). It is stated that the most frequently observed structural anomaly is cardiac [9, 19]. 
However, CNS anomalies were most frequently accompanied in another case series [20]. The 
general recommendation is that omphalocele cases detected in the first trimester and thought 
to be isolated should definitely be evaluated in the second trimester. Because it may be 
accompanied by syndromic structural conditions like Pentalogy of Cantrel; bladder exstrophy, 
imperforate anus, spina bifida complex, Beckwith–Wiedemann syndrome (2). Isolated 
omphaloceles are related to Beckwith–Wiedemann syndrome with a 10–20% probability, 
appropriate prenatal cytogenetic testing should be discussed with patients [7]. The fact that 
the negative results of molecular genetic tests do not exclude this diagnosis.  
This study has some limitations due to its retrospective structure. In addition, the lack 
of molecular cytogenetic methods is another limitation. But we have a good number of cases 
for a single center. Follow-up data is also a positive aspect in this study, because newborn 
care and surgery of cases are performed in the same hospital. 
 
CONCLUSIONS 
In conclusion, it is important to diagnose these cases in the first trimester. Intense 
efforts should be made to recognize concomitant structural and chromosomal anomalies 
because they determine the prognosis. If structural and/or chromosomal anomalies are 
present, the prognosis is poor. Genetic counseling should also be recommended in cases 
considered to be isolated. 
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Table 1. Demographic and clinical properties of the cases 
 Omphalocele n = 58 











Twin pregnancy  
 
4 (6.8%) 
Gestational week at diagnosis  
 
15.8 ± 3.7 
14.5 (12–25) 
 





Normal (n = 45) 






















SD — standard deviation 
 
Table 2. Associated anomalies and characteristics 
Associated anomalies  
 
(n%) in total 
cases  
(n = 58) 
 
% in non-





Hypoplastic left heart 
































Multicystic dysplastic kidney 











Skeletal system (short FL, short HL) 






Multiple anomalies in different systems 
 
13 (22%) 39% 
Isolated omphalocele 
 
25 (43%)  
AVSD — atrioventricular septal defect; VSD — ventricular septal defect; FL — femur length; 
HL — humerus length 
 
Table 3. Karyotype analysis and results 












2   (11%) 
1   (6%) 
 
 
Table 4. Pregnancy and delivery outcomes of the omphalocele cases 
 Omphalocele n = 58 








Gestational week at delivery  
 
34.3 ± 4.5 
36 (24–39) 
 







Birth Weight [gr] 2688 ± 586 
2700 (375–3700) 
 




Size of defect [cm] 
< 5 cm 




Content of the defect 
Bowel 
Bowel + Liver 













SD — standard deviation; IUGR — intrauterine growth restriction; C/S — cesarean section 
 
